4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-065867
Chairman and CEO bought 33,000 shares at an average $1.28 ($42,310)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-11-15 | Purchase | +2,000 | $1.25 | $2,500 | 10,888,147 | D |
| Niihara Yutaka Chairman and CEO | 2021-11-16 | Purchase | +5,000 | $1.28 | $6,400 | 10,893,147 | D |
| Niihara Yutaka Chairman and CEO | 2021-11-17 | Purchase | +13,000 | $1.29 | $16,770 | 10,906,147 | D |
| Niihara Yutaka Chairman and CEO | 2021-11-18 | Purchase | +13,000 | $1.28 | $16,640 | 10,919,147 | D |
| Open-market purchases · 33,000 sh · avg $1.28 · $42,310 | |||||||
Loading xslF345X03/doc4.xml…